Skip to main content
Publications
Whalley D , Luquiens A, Crawford SR , Laramée P, Doward LC , Price MA , Hawken N, Dorey J, Owens L, Llorca PM, Falissard B, Aubin HJ. The patient experience of alcohol use disorder . Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam.
Whalley D , Crawford SR , Laramée P, Higuchi S, Hao W, Kim S-G, Luquiens A, Aubin HJ. Cultural adaptation of the alcohol quality of life scale for use in Japan, China, and Korea . Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands.
Granero R, Hilker I, Aguera Z, Jimenez-Murcia S, Sauchelli S , Islam MA, Fagundo AB, Sanchez I, Riesco N, Dieguez C, Soriano J, Salcedo-Sanchez C, Casanueva FF, de la Torre R, Menchon JM, Gearhardt AN, Fernandez-Aranda F. Food addiction in a Spanish sample of eating disorders: DSM-5 diagnostic subtype differentiation and validation data . Eur Eat Disord Rev. 2014 Nov;22(6):389-96. doi: 10.1002/erv.2311
Kontoudis I, Harries M, Mohr P, Grange F, Ehness R, Benjamin L, Siakpere O, Barth J, Stapelkamp C, Pfersch S, McLeod LD , Kaye JA, Wolowacz SE . Economic burden of melanoma in three European countries: a retrospective observational study . Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands.
Francois C, Danchenko N, Williams VS, Nelson LM , Williams NJ, Yarr SR , DiBenedetti DB , Lancon C. Psychometric evaluation of the depression and family functioning scale (DFFS) . Poster presented at the Second Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health – Diagnosis, Prevention and Treatment in Mental Health: Effectiveness and Comparative Effectiveness; September 26, 2014. Washington, DC. [abstract] J Ment Health Policy Econ. 2014 Sep; 17(Suppl 1):S5-6.
Mohr P, Harries M, Grange F, Ehness R, Benajmin L, Siakpere O, McLeod LD , Wolowacz SE , Kaye JA, Kontoudis I. Treatment patterns and disease burden of stage IIIB/IIIC melanoma in France, Germany and the UK . Poster presented at the ESMO 2014 Congress; September 28, 2014. Madrid, Spain. [abstract] Ann Oncol. 2014 Sep 1; 25(suppl 4):iv389. doi: 10.1093/annonc/mdu344.40
Fernandez-Aranda F, Sauchelli S , Pastor A, Gonzalez ML, de la Torre R, Granero R, Jimenez-Murcia S, Banos R, Botella C, Fernandez-Real JM, Fernandez-Garcia JC, Fruhbeck G, Gomez-Ambrosi J, Rodriguez R, Tinahones FJ, Arcelus J, Fagundo AB, Aguera Z, Miro J, Casanueva FF. Moderate-vigorous physical activity across body mass index in female: moderating effect of endocannabinoids and temperament . PLoS One. 2014 Aug 7;9(8):e104534. doi: 10.1371/journal.pone.0104534
Webb S, Ware JE, Forsythe A, Yang M, Badia X, Nelson LM , Signorovitch JE, McLeod L , Maldonado M, Zgliczylski W, De Block C, Portocarrero-Ortiz L, Gadelha MR. Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing's disease . Eur J Endocrinol. 2014 Jul;171(1):89-98. doi: 10.1530/EJE-13-1013
Strober B, Zhao Y, Tran MH, Gnanasakthy A , Nelson LM , McLeod LD , Mordin M , Gottlieb A, Elewski B, Lebwohl MG. Psychometric evaluation of the Psoriasis Symptom Diary using phase 3 trial data . Poster presented at the 2014 ISPOR 19th Annual International Meeting; May 2014. Montreal, Canada. [abstract] Value Health. 2014 Jun; 17(3):A288. doi: 10.1016/j.jval.2014.03.1676